Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2009
07/02/2009WO2009081222A1 Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
07/02/2009WO2009081219A1 Quinazoline derivatives as vanilloid receptor modulators
07/02/2009WO2009081087A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof
07/02/2009WO2009016387A3 Process for the preparation of alfuzosin hydrochloride
07/02/2009WO2009012375A3 Squarate kinase inhibitors
07/02/2009US20090171086 2,4-pyrimidinediamine compounds and their uses
07/02/2009US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
07/02/2009US20090170922 Benzimidazole derivatives and their use as a medicament
07/02/2009US20090170905 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
07/02/2009US20090170903 Ester derivatives as phosphodiesterase inhibitors
07/02/2009US20090170902 Compounds which potentiate glutamate receptor and uses thereof in medicine
07/02/2009US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170870 Amidine-containing compounds useful as muscarinic receptor antagonists
07/02/2009US20090170869 Piperazine derivative having affinity for the histamine h3 receptor
07/02/2009US20090170859 Viral Polymerase Inhibitors
07/02/2009US20090170852 NOVEL PYRAZOLE-BASED HMG CoA REDUCTASE INHIBITORS
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170835 Isoindoline derivatives
07/02/2009US20090170829 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
07/02/2009US20090170814 Neurodegenerative disorders; antiinflammatory agents; antiischemic agents; neuropathic pain; antiepileptic agents; Parkinson's disease; Alzheimer's disease; antidiabetic agents; 3-(6-Hydroxy-2-methyl-3,4,7,8,9,10-hexahydro-7,10-methano-2H -benzo[h]chromen-2-yl)-propionic acid methyl ester
07/02/2009US20090167165 Organic electroluminescent device material, organic electroluminescent device, display and illuminating device
07/02/2009US20090167162 Dibenzothiophene-containing materials in phosphorescent light emitting diodes
07/02/2009CA2706372A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof
07/01/2009EP2075250A2 Thrombin receptor antagonists
07/01/2009EP2074116A2 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
07/01/2009EP2074115A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/01/2009EP2074114A1 Pyrimidinones as casein kinase ii (ck2) modulators
07/01/2009EP2074108A1 Renin inhibitors
07/01/2009EP2074107A2 Tricyclic compounds as matrix metalloproteinase inhibitors
07/01/2009EP2074106A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10
07/01/2009EP2074093A2 Matrix metalloproteinase inhibitors
07/01/2009EP2074089A2 Organic compounds
07/01/2009EP2074086A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
07/01/2009EP2074084A1 Compounds which modulate the cb2 receptor
07/01/2009EP2073799A2 Novel agents of calcium ion channel modulators
07/01/2009EP1861365B1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
07/01/2009EP1784393B1 Quinazolines useful as modulators of ion channels
07/01/2009EP1776339B1 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
07/01/2009EP1697343B1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
07/01/2009EP1691810A4 Substituted piperazines
07/01/2009EP1682126B1 Substituted benzazoles and use thereof as inhibitors of raf kinase
07/01/2009EP1611104B1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
07/01/2009CN101472919A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
07/01/2009CN101472918A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
07/01/2009CN101472917A Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (CB1) receptor ligands
07/01/2009CN101469009A Methods and compositions for treating hepatitis c virus
07/01/2009CN100506815C Piperidinyl targeting compounds that selectively bind integrins
07/01/2009CN100506807C Amide derivatives as GK activators
07/01/2009CN100506801C Inhibitors of glycogen synthase kinase 3
07/01/2009CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments
06/2009
06/30/2009US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
06/30/2009US7553972 Benzamide inhibitors of the P2X7 receptor
06/30/2009US7553971 Aryl aniline β2 adrenergic receptor agonists
06/30/2009US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/30/2009US7553867 Furan or thiophene derivative and medicinal use thereof
06/30/2009US7553848 Vanilloid receptor ligands and their use in treatments
06/30/2009US7553841 Amino cyclobutylamide modulators of chemokine receptor activity
06/30/2009US7553837 Phenylazole compounds production process and antioxidants
06/30/2009CA2510964C Therapeutic phenoxyalkylfurans and intermediates therefor
06/25/2009WO2009079624A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
06/25/2009WO2009079547A1 Quinazoline anhydrate forms
06/25/2009WO2009079541A1 Quinazoline ditosylate anhydrate forms
06/25/2009WO2009079391A1 Benzofuran anilide histone deacetylase inhibitors
06/25/2009WO2009078588A2 Composition for prevention and treatment of cancer containing pyrimidine derivatives inhibiting activity of protein phosphatases or pharmaceutically acceptable salts thereof as an active ingredient
06/25/2009WO2009077574A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
06/25/2009WO2009077500A2 Azolylmethyloxiranes, use thereof and agents containing the same
06/25/2009WO2009077068A1 Ester derivatives as phosphodiesterase inhibitors
06/25/2009WO2009077059A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
06/25/2009WO2009076693A1 Octahydroquinoli zines for antidiabetic treatment
06/25/2009WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors
06/25/2009US20090163683 Photopolymerizable monomers having epoxide and unsaturated double bonds and their composition
06/25/2009US20090163560 5-(3-(2-(4-(1-Hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; bioisosteres; vision defects; glaucoma; hypotensive agents; ocular hypertension; kits
06/25/2009US20090163549 Pharmaceutical Composition Comprising an Amide Derivative
06/25/2009US20090163518 Novel Compounds
06/25/2009US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes
06/25/2009US20090163502 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
06/25/2009US20090163498 Aryl Sulfonamides
06/25/2009US20090163497 Compounds Useful as Antagonists of CCR2
06/25/2009US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor
06/25/2009US20090163477 Phthalazinone derivatives
06/25/2009US20090162433 Method of treatment
06/25/2009US20090159841 Recovery of Optically Active Epoxy Alcohols
06/25/2009DE102007061757A1 Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung Substituted 2-phenyl-pyrimidine-5-carboxylic acids and their use
06/25/2009CA2710006A1 Octahydroquinoli zines for antidiabetic treatment
06/25/2009CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
06/25/2009CA2709068A1 Benzofuran anilide histone deacetylase inhibitors
06/24/2009EP2072515A1 Substituted quinazolidines for antidiabetic treatment
06/24/2009EP1948654B1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
06/24/2009EP1763526B1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
06/24/2009EP1611109A4 Novel quinazoline derivatives and methods of treatment related to the use thereof
06/24/2009EP1445258B1 Activator for peroxisome proliferator-activated receptor delta
06/24/2009CN101466707A Pyrrolidine derivatives useful against diseases that depend on activity of renin
06/24/2009CN101466706A Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses
06/24/2009CN101466705A Substituted enaminocarbonyl compounds
06/24/2009CN101466704A Fused ring thrombin receptor antagonists
06/24/2009CN101466686A C-FMS kinase inhibitor
06/24/2009CN100503603C Chroman compound and its preparing method and use in producing medicine
06/24/2009CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
06/24/2009CN100503600C Pesticidal heterocycles